Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Francesco Mangiapia is a clinical researcher whose work centers on robotic-assisted surgery, prostate cancer, and transplant medicine. His most impactful contributions include a systematic review on robotic-assisted laparoscopic living donor nephrectomy (RALDN), cited 37 times, which critically evaluated donor and recipient outcomes to guide surgical decision-making. He has also advanced the understanding of prostate cancer management in complex patient populations, notably through a 2022 systematic review (16 citations) examining diagnosis and outcomes in men with prior or synchronous colorectal cancer. Additionally, his analysis of perioperative red cell trends following robot-assisted radical prostatectomy (RARP), involving 453 patients, provides practical insights into blood loss management. Dr. Mangiapia’s work is characterized by rigorous evidence synthesis and a focus on improving surgical safety and patient outcomes. His research has been published in leading urology and surgery journals, reflecting his commitment to translating clinical data into actionable guidance for surgeons and oncologists. Through these studies, he has established himself as a thoughtful contributor to the fields of minimally invasive surgery and oncologic urology.